Corton Capital’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-34,960
Closed -$163K 265
2024
Q4
$163K Buy
+34,960
New +$192K 0.09% 292
2024
Q2
Sell
-22,975
Closed -$163K 595
2024
Q1
$163K Buy
+22,975
New +$152K 0.06% 440
2023
Q3
Sell
-19,137
Closed -$106K 453
2023
Q2
$106K Buy
+19,137
New +$103K 0.05% 399
2022
Q4
Sell
-13,177
Closed -$62K 335
2022
Q3
$62K Buy
+13,177
New +$83.1K 0.08% 256
2022
Q2
Sell
-14,829
Closed -$287K 404
2022
Q1
$287K Buy
+14,829
New +$340K 0.12% 249

Other funds holding GDRX

Corton Capital's GDRX Position: Q1 2025 in Review

Corton Capital sold out of GoodRx Holdings (GDRX) in Q1 2025, closing a stake of 34,960 shares — an estimated $163K sold.

Corton Capital first reported a position in GDRX in Q1 2022 and held it in 5 quarters. The position peaked at $287K in Q1 2022. 170 funds tracked by Wall St. Rank hold GDRX as of Q1 2025.

  • Corton Capital reported no remaining GoodRx Holdings position as of Q1 2025 after selling out during the quarter.
  • Corton Capital sold 34,960 GoodRx Holdings shares in Q1 2025, an estimated $163K.
  • Corton Capital first reported a position in GoodRx Holdings in Q1 2022 and held it in 5 quarters.
  • Corton Capital's GoodRx Holdings position peaked at $287K in Q1 2022.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2025.

Based on Corton Capital's 13F filing for Q1 2025, filed 7 May 2025.